VR-CHOP regimen

Jump to navigation Jump to search

WikiDoc Resources for VR-CHOP regimen

Articles

Most recent articles on VR-CHOP regimen

Most cited articles on VR-CHOP regimen

Review articles on VR-CHOP regimen

Articles on VR-CHOP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on VR-CHOP regimen

Images of VR-CHOP regimen

Photos of VR-CHOP regimen

Podcasts & MP3s on VR-CHOP regimen

Videos on VR-CHOP regimen

Evidence Based Medicine

Cochrane Collaboration on VR-CHOP regimen

Bandolier on VR-CHOP regimen

TRIP on VR-CHOP regimen

Clinical Trials

Ongoing Trials on VR-CHOP regimen at Clinical Trials.gov

Trial results on VR-CHOP regimen

Clinical Trials on VR-CHOP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on VR-CHOP regimen

NICE Guidance on VR-CHOP regimen

NHS PRODIGY Guidance

FDA on VR-CHOP regimen

CDC on VR-CHOP regimen

Books

Books on VR-CHOP regimen

News

VR-CHOP regimen in the news

Be alerted to news on VR-CHOP regimen

News trends on VR-CHOP regimen

Commentary

Blogs on VR-CHOP regimen

Definitions

Definitions of VR-CHOP regimen

Patient Resources / Community

Patient resources on VR-CHOP regimen

Discussion groups on VR-CHOP regimen

Patient Handouts on VR-CHOP regimen

Directions to Hospitals Treating VR-CHOP regimen

Risk calculators and risk factors for VR-CHOP regimen

Healthcare Provider Resources

Symptoms of VR-CHOP regimen

Causes & Risk Factors for VR-CHOP regimen

Diagnostic studies for VR-CHOP regimen

Treatment of VR-CHOP regimen

Continuing Medical Education (CME)

CME Programs on VR-CHOP regimen

International

VR-CHOP regimen en Espanol

VR-CHOP regimen en Francais

Business

VR-CHOP regimen in the Marketplace

Patents on VR-CHOP regimen

Experimental / Informatics

List of terms related to VR-CHOP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

VR-CHOP regimen refers to a regimen consisting of velcade (bortezomib), rituximab, cyclophosphamide, hydroxydaunorubicin (doxorubicin), oncovin (Vincristine), prednisone used to treat previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.[1] .

Regimen

VVelcade (Bortezomib)

RRituximab

CCyclophosphamide

HHydroxydaunorubicin (Doxorubicin)

OOncovin (Vincristine)

PPrednisone

Indications

References

  1. 1.0 1.1 Ruan J, Martin P, Furman RR, Lee SM, Cheung K, Vose JM; et al. (2011). "Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma". J Clin Oncol. 29 (6): 690–7. doi:10.1200/JCO.2010.31.1142. PMID 21189393.